Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rafael Holdings, Inc. Class B Common Stock (NY:RFL)

1.810 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 944
Open 1.810
Bid (Size) 1.850 (17)
Ask (Size) 1.950 (7)
Prev. Close 1.810
Today's Range 1.810 - 1.810
52wk Range 1.290 - 2.500
Shares Outstanding 100
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the... 
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire

Performance

YTD
+2.8%
+2.8%
1 Month
-1.6%
-1.6%
3 Month
+2.8%
+2.8%
6 Month
-8.1%
-8.1%
1 Year
+1.7%
+1.7%

More News

Read More
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
RFL Stock Earnings: Rafael Holdings Reported Results for Q3 2024
Via InvestorPlace
RFL Stock Earnings: Rafael Holdings Reported Results for Q1 2024
Via InvestorPlace
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, SMC, COFS, RFL on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, RVNC, ARC, RFL on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COFS, ARC, NBY, RFL on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq - CFB), Arch Resources, Inc. (NYSE - ARCH), Cyclo Therapeutics, Inc. (Nasdaq - CYTH), Vector Group Ltd. (NYSE - VGR)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq - CFB), Arch Resources, Inc. (NYSE - ARCH), Cyclo Therapeutics, Inc. (Nasdaq - CYTH), Vector Group Ltd. (NYSE - VGR)
From Brodsky & Smith LLC
Via GlobeNewswire
RFL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Rafael Holdings, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement
From Cyclo Therapeutics, Inc.
Via Business Wire
Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement
From Rafael Holdings, Inc.; Cyclo Therapeutics
Via GlobeNewswire
Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
From Cyclo Therapeutics, Inc.
Via Business Wire
Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.
From Cyclo Therapeutics, Inc.
Via Business Wire
Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
From Rafael Holdings, Inc.
Via GlobeNewswire
Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement
From Cyclo Therapeutics, Inc.
Via Business Wire

Frequently Asked Questions

Is Rafael Holdings, Inc. Class B Common Stock publicly traded?
Yes, Rafael Holdings, Inc. Class B Common Stock is publicly traded.
What exchange does Rafael Holdings, Inc. Class B Common Stock trade on?
Rafael Holdings, Inc. Class B Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Rafael Holdings, Inc. Class B Common Stock?
The ticker symbol for Rafael Holdings, Inc. Class B Common Stock is RFL on the New York Stock Exchange
What is the current price of Rafael Holdings, Inc. Class B Common Stock?
The current price of Rafael Holdings, Inc. Class B Common Stock is 1.810
When was Rafael Holdings, Inc. Class B Common Stock last traded?
The last trade of Rafael Holdings, Inc. Class B Common Stock was at 04/03/25 07:00 PM ET
What is the market capitalization of Rafael Holdings, Inc. Class B Common Stock?
The market capitalization of Rafael Holdings, Inc. Class B Common Stock is 181.00
How many shares of Rafael Holdings, Inc. Class B Common Stock are outstanding?
Rafael Holdings, Inc. Class B Common Stock has 181 shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.